Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-3948
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use ; day:3 ; month:9 ; year:2019 ; pages:1-14
Drug Delivery and Translational Research ; (3.9.2019), 1-14
- Creator
-
Chen, Kent T. J.
Anantha, Malathi
Leung, Ada W. Y.
Kulkarni, Jayesh A.
Militao, Gardenia G. C.
Wehbe, Mohamed
Sutherland, Brent
Cullis, Pieter R.
Bally, Marcel B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13346-019-00674-7
- URN
-
urn:nbn:de:101:1-2020011607005029745898
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Kent T. J.
- Anantha, Malathi
- Leung, Ada W. Y.
- Kulkarni, Jayesh A.
- Militao, Gardenia G. C.
- Wehbe, Mohamed
- Sutherland, Brent
- Cullis, Pieter R.
- Bally, Marcel B.
- SpringerLink (Online service)
Other Objects (12)
Development and characterization of liposomal formulation of bortezomib
Oil-based parenteral depot formulation for veterinary peptide delivery
Effect of liposomal formulation of ascorbic acid on corneal permeability
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
Publisher Correction: The influence of liposomal quercetin on liver damage induced by microwave ablation
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Development of a copper-clioquinol formulation suitable for intravenous use
A nano-Liposomal formulation potentiates antioxidant, anti-inflammatory, and fibrinolytic activities of Allolobophora caliginosa coelomic fluid: formulation and characterization
Development and characterization of liposomal formulation of bortezomib
Oil-based parenteral depot formulation for veterinary peptide delivery
Effect of liposomal formulation of ascorbic acid on corneal permeability
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
Publisher Correction: The influence of liposomal quercetin on liver damage induced by microwave ablation
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Development of a copper-clioquinol formulation suitable for intravenous use
A nano-Liposomal formulation potentiates antioxidant, anti-inflammatory, and fibrinolytic activities of Allolobophora caliginosa coelomic fluid: formulation and characterization
Development and characterization of liposomal formulation of bortezomib
Oil-based parenteral depot formulation for veterinary peptide delivery
Effect of liposomal formulation of ascorbic acid on corneal permeability
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
Publisher Correction: The influence of liposomal quercetin on liver damage induced by microwave ablation
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Development of a copper-clioquinol formulation suitable for intravenous use